[Does the authentication of the antibodies against Helicobacter pylori have contribution to its diagnosis?]
Related Experiment Video
Updated: Jun 3, 2026

Rapid Detection of Fecal Antigen of Helicobacter pylori Infection Based on Double Antibody Sandwich Detection Technology
Published on: May 23, 2025
1Oddéleni Klinické Mikrobiologie, Pardubická Krajska Nemocnice, a.s., Pardubice a FZS Univerzity Pardubice. eva.zalabska@nemocnice-pardubice.cz
Abstract:
Generally, it is possible to use both invasive and non-invasive methods for the diagnosis of Helicobacter pylori infection. One of the non-invasive methods not requiring endoscopic examination of the patient is, besides the breath test and stool antigen test, serological detection of the antibodies. Antibodies are determined in the IgM, IgG and IgA classes using the ELISA method with a sensitivity of 82-96 % and specificity of 67-92 %. Confirmation with the Western blot allows more precise specification of the infection. At the same time, it is possible to identify individual specific antibodies against Helicobacter pylori antigens. It allows determination of antibodies against CagA which is considered an important virulence marker. The study comprised 447 sera from patients tested by ELISA to determine antibodies against Helicobacter pylori in the IgG and IgA classes in 2009-2010 (since 2010 also in the IgM class). Additionally, two interesting case reports are presented.
More Related Videos
05:23Gastric Mucosa Quantitative Polymerase Chain Reaction Analysis for Detecting Helicobacter pylori and Antibiotic Resistance
Published on: March 7, 2025
04:56Detection of Helicobacter pylori Infection and Antibiotic Resistance via Stool Quantitative Polymerase Chain Reaction Analysis
Published on: May 16, 2025
Related Concept Videos
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Gastritis II: Pathophysiology
Peptic Ulcer Disease II: Pathophysiology
Peptic Ulcer Disease II: Pathophysiology
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Peptic Ulcer